Background: Hypothyroidism is a decrease in the production of the thyroid hormones and leads to gland dysfunction. Spirulina used as an antioxidant and supposed as antihypothyroidic agent. Objective: This study was carried out to investigate the impact of Spirulina on PTU-induced hypothyroidism in rats.
INTRODUCTION
The thyroid gland is one of the important endocrine glands that play an essential vital role in the metabolism and energy expense in the body [1] . This gland is responsible for production, storage, and releasing of the thyroid hormones triiodothyronine (T3) and thyroxine (T4) [2] . Quantitively, (T4) is the predominant hormone, while (T3) is biologically more active and arises from the peripheral deiodination of T4 [3and4] . The thyroid hormones have a necessary role in controlling and keep on the proper developmental and physiological functions [5] . Also, an adequate supply of Iodine is necessary for the regular production of the thyroid hormones [6] . Hypothalamus-pituitary-thyroid axis regulates the biosynthesis and secretion of the thyroid hormones. So, the dysfunction of this axis results in an abnormal state, which is exhibited as either hyper-or hyposecretion of hormones that impacted the human body health [7and8] .
Hypothyroidism is a clinical condition that is one of the most common thyroid diseases. In the hypothyroidism, high level of thyroid-stimulating hormone (TSH) are recorded and hyperstimulation of the follicular cells that lead to the changes in the metabolism due to the low production of T3 and T4 [9,10and11] . Propylthiouracil is recorded as one of the drugs that induce the hypothyroidism [12] [13] [14] . Propylthiouracil (six-n-propyl-2-thiouracil) (PTU) is a thiocarbamidederived drug used as an anti-thyroid agent [15] . PTU is considered as one of the vital agents who can initiate hypothyroidism by reducing circulating levels of T3 and T4 and increasing levels of TSH by inhibition of hypoperoxidase as well as peripheral deiodinase [16] .
Spirulina (Arthrospira) is a spiral blue-green microalga belonging to the class of cyanobacteria [17] [18] [19] [20] [21] . The term of Spirulina represents the dry biomass of the genus Arthrospira sp. [22] . Spirulina is a rich source of phycocyanin, carotenoids, biliprotein pigment, proteins, phenolic acids, iodine, and vitamins [23] . Moreover, the high active ingredient of C-phycocyanin in spirulina makes it exhibit activities such as an anti-inflammatory, antioxidant; immunomodulatory, hepatoprotective, nephroprotective, neuroprotective, antidiabetic, antigenotoxic, antitoxic, antihypertensive and anticancer [24] [25] [26] [27] [28] [29] [30] . Due to such biological properties about Spirulina, the current study was designed to examine for the first time the ameliorative potential of this alga against the hypothyroidism induced by PTU in albino rats.
MATERIALS AND METHODS

Chemicals
Spirulina tablets were purchased from Puritan's Pride Company, Inc. (USA). Each tablet contains 500 mg of the active ingredient. The drug is ground and administered orally in the form of a suspension in 0.9% saline. Propylthiouracil is available under the name of Thyrocil® (Amoun Pharmaceutical Co., Egypt) as white discoid tablets containing 50 mg of the active ingredient.
Laboratory animals
Forty-two healthy adult male Wistar albino rats (Rattus norvegicus) weighing 120-140g, were obtained from the Medical Research Center at the Faculty of Medicine, Ain Shams University (Cairo, Egypt). The rats were transported to the animal care unit at the Zoology Department, Faculty of Science, Ain Shams University, two weeks before the starting of the experiment for acclimatization to laboratory conditions. The animals were reared in clean and adequately ventilated cages and bedded on fresh wood shavings. A temperature of 25°C and a 12h light/dark cycle maintained. Free access to water and standard rodent food pellets were available to the animals. All efforts were made to minimize animal suffering and to use only the number of animals necessary to produce reliable scientific data. All animal experiments comply with the National Institutes of Health guide for the care and use of Laboratory Animals (NIH Publications No. 8023, revised 1985) , and the experimental protocol was approved by the Ain Shams University Research Ethics Committee.
Experimental design
Rats were divided into six groups, each of 7 rats, as follows: The control group (G1): rats ingested saline solution. PTU-group (G2): rats treated orally with 50 mg/ kg body Wt./day of Propylthiouracil. SP-500 (G3): rats were administered oral dose 500 mg/kg body Wt./day of Spirulina. SP-1000 (G4): rats treated orally with 1000 mg/kg body Wt./day of Spirulina. PTU+ SP-500 (G5): rats were administered oral dose 50 mg/kg body Wt./ day of Propylthiouracil and 500 mg/kg body Wt./day of Spirulina.PTU+SP-1000 (G6): rats treated orally with 50 mg/kg body Wt./day of Propylthiouracil and 1000 mg/kg body Wt./day of Spirulina. The treatments were achieved orally by using a gastric tube for the period of 14 days. In the co-administrated groups, the Spirulina was given first, and then after 1 hour, the Propylthiouracil drug was administered.
Sample collection
At the end of the experiment, the rats were weighed, anesthetized using chloroform, and then necropsied. Blood samples were taken from the heart puncture and centrifuged. The supernatant serum was divided into equal amounts (approximately 200 µl) and frozen at -80 until being assayed for T3, T4, and TSH. The thyroid glands were isolated from the surrounding tissue and processed for the histological examination.
Histological procedures
Thyroid gland samples were fixed in 10% formalin solution at room temperature for 24h. Samples were then dehydrated in ascending grades of ethyl alcohol, cleared in terpineol and embedded in paraffin wax. Paraffin sections 5μm thick were stained with Hematoxylin and Eosin. Photomicrographs were taken using a camera attached to a Leica DM LS2 microscope (Leica Microsystems, Wetzlar, Germany) at the Regional Center for Mycology and Biotechnology, El-Azhar University.
Immunohistochemistry
In El-Demerdash Hospital, Immunohistochemistry laboratory detection of Ki-67 marker for cellular proliferation was carried out. The tissues were fixed in 10% formalin, dehydrated, cleared, and then embedded in paraffin. Sections of 5 µm were deparaffinized and hydrated in ascending series of alcohols. The tissue sections were incubated with 3% H 2 O 2 solution for 20 min at 27°C. Then incubated with standard goat serum working solution (Biosharp, Hefei, China) for 30 min at 27°C. Next, the sections were incubated overnight at 4°C with mouse monoclonal Ki-67 antibody (dilution, 1:500; cat. no. WH0004288M1) from Sigma (St. Louis, MO, USA). Goat anti-mouse IgG secondary polyclonal antibodies (dilution, 1:1,000; cat. no. ab6789; Abcam, Cambridge, MA, USA) were used next for incubation at 27°C for 20 min. Finally, the sections were incubated with horse-radish peroxidase-labeled streptavidin working solution at 27°C for 20 min. The sections were washed with PBS 3 times, each for 5 min, and DAB solution was added. The sections were counterstained with hematoxylin to stain nuclei, dehydrated, cleared in xylene and mounted with DPX. The sections were examined and photographed using a camera attached to a Leica DM LS2 microscope (Leica Microsystems, Wetzlar, Germany) at the Regional Center for Mycology and Biotechnology, El-Azhar University.
Morphometric measurements
The image analysis system (Leica Q 500 MC program) at the Regional Center for Mycology and Biotechnology, El-Azhar University, was used to measure:1-The height of the follicular epithelium in HandE-stained slides. 2-The follicular diameter in HandE-stained-slides. Five different nonoverlapping microscopic fields from each specimen in every studied group were examined for the parameters mentioned earlier at a magnification of X 40.
Hormonal assays
Serum triiodothyronine (T3), thyroxine (T4), and thyroid-stimulating hormone (TSH) were measured by electrochemiluminescence immunoassay on a Cobas® e601 immunoassay analyzer (Roche-Hitachi Diagnostics, Mannheim, Germany). The hormones were assessed according to manufacturer's instructions using commercially available kits from Biodiagnostics (Cairo, Egypt).
Statistical analysis
Mean values and the standard error reported as numerical data. GraphPad Prism (version 5.0, GraphPad Software, San Diego, CA, USA) was used to conduct all statistical analysis. Data were analyzed statistically using one-way ANOVA followed by post hoc multiple comparisons (Tukey's test) for a comparative study between the groups. P<0·05 was regarded as statistically significant.
RESULTS
Bodyweight
The rats treated with the different doses of Spirulina or PTU revealed a significant decrease in their body weight gain in comparison to that of the control rats (Table 1) . Moreover, a significant decrease in body weight gain was shown in the PTU-group treated with the different doses of Spirulina compared to the PTU-group alone, and this decrease has become dose-dependent. A loss of appetite during the experiment, as well as decreased-locomotor activities was observed in all groups except the control group.
Hormonal results
Results of the thyroid hormones' level (T3, T4, and TSH) of the control group are represented in ( Table 2) . Treatment of rats with the different doses of Spirulina revealed more or less similar hormone levels as those of the control group (Table 2) , and after PTU treatment, level of T3 and T4 in circulation was significantly decreased, while the level of TSH increased significantly compared to the control group. Whereas the treatment of PTU-group with the different doses of Spirulina exhibited an improvement in the level of the hormones, but this improvement was insignificant and related to the proposed doses.
Morphometric results
Moderate enlargement of the thyroid gland was revealed in all experimental groups compared to the control group. The gland was firm in texture and darker in color than that in control. The morphometric measurements of the thyroid follicles' diameters and heights of the cubical epithelial cells of the control group were recorded in (Table 3 ). It is clear that the follicular diameter significantly increased in the treated groups with the different doses of Spirulina, while the epithelial height was insignificantly increased in the low dose of Spirulina and increased dramatically in a high dose of spirulina compared to the control group.
In the PTU-group, there was a significant increase in the morphometry of these parameters compared to the control group. On the other hand, the treatment of PTU-group with the different doses of Spirulina hasn't revealed any remarkable change in these measurements compared to the corresponding PTU-group.
Histological results
Tissue sections of the thyroid gland of the control group (G1) showed well-formed, tightly packed follicles separated by narrow interfollicular tissue, which contains connective tissues with blood capillaries and clusters of interfollicular cells ( Figure 1A) . The thyroid follicles are variable in size and shapes, filled with a homogeneous acidophilic colloidal substance with the peripherally fine vacuolated regions. The follicles are lined by a single layer of low cuboidal cells having rounded nuclei ( Figure 1B ).
There were many histopathological changes in all treated groups. Thyroid tissue of the induced hypothyroid group (G2) showed less well-rounded thyroid parenchyma ( Figure 2A ). The thyroid follicles were disorganized with irregular follicular walls and highly congested blood capillaries. The thyroid follicles appeared with empty lumina, lined mostly with high cuboidal cells containing hyperchromatic nuclei. Some of the follicular cells exhibited apparent cytoplasmic vacuolation. Also, Both follicular cells and the interfollicular cells revealed moderate hyperplasia ( Figure 2B ).
The histological examination of the thyroid gland tissue sections of groups that were treated with two different doses of Spirulina; the low dose-treated group (G3) and the high dose-treated group (G4) showed irregular thyroid follicles with an apparent increase in the follicular diameter and increase in the heights of the lining cells ( Figures 3A and 4A ). The follicles were disrupted and depleted and with vacuolated colloid ( Figures 3B and 4B ). Signs of hyperactivity were observed in most of the follicles ( Figures 3C and 4B ). Many of the thyroid follicles were obliterated due to the noticeable highly cellular hyperplasia of the follicular and interfollicular cells making papillary growth ( Figure 3C ). The presence of hyperchromatic nuclei characterized the hyperplastic cells and accompanied by nuclear changes in size and shape ( Figures 3B and 4C ). The lumina of the follicles were excessively filled with vacuolated thyroglobulin and formation of the papillary structure due to the hyperplasia of the epithelial cells was seen ( Figure 4C ). Severe bleeding and congestion of interfollicular capillaries were markedly observed ( Figure 4B) ; especially in the tissues of the high dose of spirulina-treated group G4 ( Figure 4B ).
Slight improvement in the architecture of the thyroid gland tissues was observed in PTU+ Spirulina treated groups (G5 and G6) ( Figures 5 and 6 ). Less hyperplastic activity in the variable-sized thyroid follicles, in addition to partially filled colloid, were observed ( Figures 5A and 6A) . Some follicles uniformly appeared lined with cuboidal cells, and others were lined with low columnar cells ( Figures 5B and 6B) . The vacuolated follicular cells have become less than that appeared in the Spirulina treated group ( Figure 5C ). Typical rounded thyroid follicles were more or less restored ( Figure 5B) . Also, the thyroglobulin has become more homogeneous and filled the follicular lumina of the thyroid tissue ( Figure 6B) . Also, the disappearance of the bleeding and the high congestion of the blood capillaries in the gland tissues, especially in the tissues of the high dose of Spirulina and PTU treated group were recorded (G6) ( Figure 6B ).
Immunohistochemical results
The immunohistochemical results revealed the negative expression of kI-67 in the nuclei of the follicular epithelial cells in the tissues of the thyroid gland of the control group (G1) ( Figure 7A ). Also, very weak KI-67 immunoreactivity was shown in thyroid gland sections of the PTU treated group (G2) ( Figure 7B ).
There was no KI-67 reaction observed in the sections of the thyroid gland of treated rats with both low and high doses of Spirulina (G3 and G4) ( Figures 8A and 8B) , respectively. On the other hand, nuclei of the epithelial cells lining the thyroid follicles of groups (PTU+ Spirulina) (G5 and G6) revealed weak to moderate KI-67 expression ( Figures 9A and 9B ) in comparison with both the control group ( Figure 1A) and hypothyroidism (PTU) group (G2) ( Figure 2B ). 
DISCUSSION
The thyroid gland is an endocrine gland that is responsible for the production, storage, and release of thyroid hormones triiodothyronine (T3) and thyroxin (T4). These hormones are essential for cell growth and development [31] . One of the thyroid disorders is hypothyroidism which is defined as a deficiency in thyroid hormones production as a result of dysfunction of the thyroid gland leading to disruption of the synthesis and secretion of hormones [32] .
The current investigation aimed to evaluate the hormonal, histological, and immunohistochemical changes in hypothyroid-model, also to assess whether Spirulina has potential ameliorating effects against hypothyroidism. The present work designed to be carried out with several experimental animals that was enough to get real and confirmed results. Whereas, the various articles in the fields of applied toxicological developmental and pharmaceutical work caring to use enough animals to expect the primary outcomes.
One of the most important observations was the decrease in body weight gain in rats treated with PTU compared to the control group, as previously reported in various studies [33] . This decrease could be attributed to the decline in levels of T3 and T4 that have a potential effect on the metabolism and homeostasis in animal body. Also, certain study referred to the previous result of impairment in energy metabolic processes along with a decrease in the basal metabolic rate [34] . Moreover, a significant decline in the body weight gain was observed in the rats that have been treated with the different doses of Spirulina compared to those of control rats. This finding is supported by the results of earlier studies, which reported that treatment with Spirulina leads to the suppression of body weight gain and body mass index [35] [36] [37] [38] . Also, this result might be attributed to the loss of appetite during the experiment. This interpretation is supported by Mazokopakis et al. (2014b) , who reported that Spirulina is rich in phenylalanine, a potent releaser of cholecystokinin that affects the brain's appetite center, which in turn suppress the body weight. On the other hand, the reduction effect of Spirulina on body weight is due to its antioxidant properties through decreasing the lipase, suppression of food intake, and the regulation effect on lipid metabolites [39and40] .
Biochemically, PTU induced the hypothyroidism that is reflected in the recorded hormonal levels of T3, T4, and TSH. A significant decrease in the serum T3 and T4 concentration was observed in the statistical analysis; also, the TSH recorded a significant increase compared to the control values. The present results agreed with several previous studies [41and42] . The principle of the PTU action mechanism depends on that the thyroid peroxidase enzyme 
Seven rats per group
Values are expressed as means ± SEM (n=7/G) * indicates the significant difference of SP-treated groups and PTU-group vs. the control group** p<0.01,***p<0.001. ♯ indicates the significant difference of SP-treated groups vs. the PTU group ♯♯♯ p<0.001. controls T4 production that inhibits the secretion of the thyroid hormones and inhibits the conversion of the active form of T4, T3 in peripheral tissues [43and44] .
In the current study, the histological findings of thyroid gland confirmed the hypothyroid status such as hyperplasia signs, cellular cytoplasmic vacuolation, dilated congested blood capillaries, and the increase in the height of the follicular cells, besides the increase in the diameters of the thyroid follicles. In addition, degenerated and vacuolated thyroglobulin masses were shown in the follicular cells and the interfollicular cells. Similar results were described by Underwood et al., (2009) [45] .
The cellular cytoplasmic vacuolation could be due to fluid accumulation and glandular overstimulation, or due to hydropic and vacuolar degeneration [46] . Furtherly, the observed increase in follicular epithelium height that was confirmed statistically compared with the control group may be due to the hyperactivity of the cells, which were stimulated by the high level of the TSH hormone. Similar results have been previously reported by other researchers [47] . Also, the observed increase in the height of the cells can be explained by the increased functional capacity that resulted from the increased substantive demand. Cellular hyperplasia can be attributed to the stimulation of resting cells to enter the cell cycle (G1) to divide in response to the changed endocrine milieu and increased functional demand for injury [48] .
In our study, the increased TSH levels in hypothyroidism model were in agreement with Standring (2008) [49] who reported that prolonged high levels of circulating TSH induces the follicular cell hyperplasia and increase the stromal vascularity. Moreover, Ramsden (2000) [50] reported that the increase of TSH causes the vascular endothelial growth factor produced in the thyroid, and this factor is a potent angiogenic protein that is responsible for the vascularization.
In the present study, the PTU-treated group showed peripheral colloidal degeneration and vacuolation with most of the thyroid follicles. Since PTU does not affect the iodinated thyroglobulin already stored in the gland [51] , so it could be suggested that follicular cells increase their activity in taking up and releasing thyroid hormones into the circulation to compensate for the increased demand [52] .
Also, the current results reported insignificant changes in the hormonal levels in the treated rats with the low or high doses of Spirulina, while remarkable histopathological changes in the thyroid sections in a dose-dependent manner were noticed compared to control group. As far as the authors are aware, no previous reported studies were carried out on the direct or indirect effects of Spirulina on the thyroid gland.
The current study reported that the co-administration of PTU-group with Spirulina resulted in an insignificant increase in T3 and T4 levels and negligible decrease in the TSH level. Also, to a slight improvement in the thyroid histological structure compared to the PTU-group. It could be interpreting that the histopathological changes have resulted from hyper-stimulation of TSH in the PTU group, and these changes also slightly improved by the limited decrease in TSH. These slight improvements appeared as a reduction in the congestion of blood capillaries and little restoration of thyroglobulin in the follicles. So, Spirulina cannot ameliorate the impact of PTU completely. The proposed results in this work are in a disagreement with a previous study reported by Assoc (2002) [53] who recorded that Spirulina is a nutritional and therapeutic supplement giving rise healthy markers and good vital indicators on the body's homeostasis. Moreover, Liu et al., (2006 [54] reported that Spirulina had a positive effect on the hematopoietic recovery and related cytokines in mice. Also, Chu et al., (2010) [55] verified that the aqueous extract from Spirulina has a protective effect against cell death.
Based on the few existing studies, there are beneficial allergic and immunological effects of consumption of bluegreen algae Spirulina [56and57] . In the proposed work, the cells stained with KI-67 antigen nuclear protein for the cellular proliferation showed some positive cells in the tissues of PTU+Spirulina (500 and 1000 mg/kg/body wt.) treated groups while the tissues of Spirulina' groups alone revealed negative expression for KI-67 marker. Also, the existence of hyperplasia in the tissues due to the hyperactivity of the cells could be explained by various studies that mentioned the possibility of transformation of the hyperplasia into benign or malignant tumors depending upon the physiological factors and responses [58] . Also, according to the reactions due to the excess of hormones or growth factors could be responsible for the stimuli [59] . Moreover, the pathologic hyperplastic cells may be changed into neoplastic cells due to genetic aberrations which control the proliferated cells in a non-physiological way, and they have not a response to the normal stimuli [60,61and62] .
More recorded studies reported that the Spirulina could be used within the drugs to reduce their side effects of the drugs on the metabolism and to increase the efficiency of the immune system of the body [63] . It has been well documented that Spirulina has anti-inflammatory properties, through inhibiting the release of histamine from mast cell-mediated allergic reactions [64and65] . So, in the present study, it can be concluded that the reduction of bleeding and decrease of congestion in the blood capillaries in the thyroid gland in PTU+ Spirulina treated groups is due to the anti-inflammatory effect of the Spirulina.
The signs of improvement in thyroid tissue of rats treated by PTU and Spirulina might be due to the iodide content of the Spirulina. Moreover, the iodine intake actively plays a vital role in the functions and performance of the gland, as well as keeping the metabolism and homeostasis stable and in a normal manner [66] . Also, it was reported that the blue-green algae Spirulina has antioxidant and antiapoptotic properties, which make it reduces the cell injuries, improve the enzyme functions, and prevent the oxidation process in the body. Also, its content of vitamins, superoxide dismutase, minerals and the C phycocyanin which is a protein-bound pigment found in Spirulina, inhibits oxalate-mediated lipid peroxidation and prevents injury in many tissues [67and68] .
In conclusion, the treatment of the induced hypothyroid rat with the two doses of Spirulina resulted in slight improvement and restoration of the thyroid histological architecture and hormonal levels. On the contrary, treatment with Spirulina alone resulted in remarkable high hyperplasia as a cellular change at the two studied experimental doses. In the current study, both selected low and high doses of Spirulina that have been chosen were different than those recorded in other various experimental studies. Moreover, the impact of Spirulina on the hypothyroid model has a slight ameliorating effect on the histological structure, but care should be taken because the hyperplastic cells can be transformed into benign or malignant tumors. This assumption is aided by the appearance of some positively expressed nuclei with the KI-67 marker of proliferation. So, caution should be used in extrapolating these results to the human being. Additionally, may be the application of the present study with more long terms and different doses of Spirulina give different results.
